Status:

RECRUITING

Fatty Acid Modulation of Brain Function in Older Adults

Lead Sponsor:

University of Vermont

Conditions:

Aging

Eligibility:

All Genders

65-75 years

Phase:

NA

Brief Summary

In this crossover study, the investigtors will administer two experimental diets in a random order for one week, and each experimental diet will be preceded by a one-week, low fat control diet for a t...

Detailed Description

This study will examine how manipulating dietary fatty acids affects brain functioning in older adults. Prior studies have shown that there are behavioral changes that can be made to improve cognition...

Eligibility Criteria

Inclusion

  • Men and women age range 65-75 years
  • Normal cognition (see Research Strategy for details on cognitive assessments)
  • "Healthy" (body mass index (BMI) of 20-40 kg/m2)

Exclusion

  • Significant cognitive or behavioral impairment (see Research Strategy for testing and exclusions) or pharmacological treatment for this (e.g. antipsychotics, anxiolytics, and sedative medications).
  • Hormone replacement therapy, past 3 months.
  • Hyper-androgenic condition.
  • HbA1C≥7.5% and or Fasting plasma glucose concentration ≥130 mg/dL.
  • Type 2 Diabetes if receiving any other therapy than metformin.
  • Use of nicotine or ingestion of caffeine or alcohol during the study.
  • Habitual fat intake \< 25% of kcal or strict vegetarian diet.
  • Sleep apnea requiring continuous positive airway pressure at night.
  • Lung, cardiac (heart failure or its treatment), liver disease, renal disease, cancer, and any other medical disorder known or thought to cause inflammation or abnormalities of cognition
  • Actively training for an athletic event or participating in competitive sports (such as league play or tournaments)
  • Intolerance or allergy to any of the food provided in the study.

Key Trial Info

Start Date :

April 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 31 2028

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06192407

Start Date

April 15 2024

End Date

October 31 2028

Last Update

September 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Vermont

Burlington, Vermont, United States, 05401